Vamsi Parimi

1.3k total citations
38 papers, 918 citations indexed

About

Vamsi Parimi is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Vamsi Parimi has authored 38 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Vamsi Parimi's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Vamsi Parimi is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Vamsi Parimi collaborates with scholars based in United States, Egypt and Philippines. Vamsi Parimi's co-authors include Ximing J. Yang, Kate Poropatich, Andrés Matoso, Woonyoung Choi, Jean Hoffman‐Censits, Noah M. Hahn, Kara A. Lombardo, David J. McConkey, Elden P. Swindell and Jeffrey D. Clogston and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Vamsi Parimi

37 papers receiving 912 citations

Peers

Vamsi Parimi

ONCOL

PRM

SURGE

L-T. Chen Taiwan

Junxin Wu China

Germana Tognon Italy

Tingyan Shi China

Joanne I. Adamkewicz United States

Elisa Gruppioni Italy

Zuzana Čierna Slovakia

Wen Liu China

Jene Choi South Korea

Noreli Franco United States

L-T. Chen Taiwan

Vamsi Parimi

252 ×0.7

299 ×1.1

ONCOL

238 ×1.0

PRM

233 ×1.2

SURGE

203 ×1.2

Citations per year, relative to Vamsi Parimi Vamsi Parimi (= 1×) peers L-T. Chen

Countries citing papers authored by Vamsi Parimi

Since Specialization

Citations

This map shows the geographic impact of Vamsi Parimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vamsi Parimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vamsi Parimi more than expected).

Fields of papers citing papers by Vamsi Parimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vamsi Parimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vamsi Parimi. The network helps show where Vamsi Parimi may publish in the future.

Co-authorship network of co-authors of Vamsi Parimi

This figure shows the co-authorship network connecting the top 25 collaborators of Vamsi Parimi. A scholar is included among the top collaborators of Vamsi Parimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vamsi Parimi. Vamsi Parimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Huili, Vamsi Parimi, Burles A. Johnson, et al.. (2025). Clinicopathologic and Prognostic Features of Sarcomatoid Urothelial Carcinoma. The American Journal of Surgical Pathology. 50(1). 51–61.

Johnson, Burles A., Vamsi Parimi, David C. Corney, et al.. (2025). Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells. The Journal of Pathology Clinical Research. 11(2). e70021–e70021. 1 indexed citations

Parimi, Vamsi, Khaled Tolba, Natalie Danziger, et al.. (2023). Genomic landscape of 891 RET fusions detected across diverse solid tumor types. npj Precision Oncology. 7(1). 10–10. 34 indexed citations

Parimi, Vamsi, Woonyoung Choi, Mingxiao Feng, et al.. (2023). Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small‐cell carcinoma of the bladder. Histopathology. 82(7). 991–1002. 3 indexed citations

Danziger, Natalie, Ethan Sokol, Ryon P. Graf, et al.. (2023). Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay. The Oncologist. 28(4). 319–326. 8 indexed citations

Grivas, Petros, Gennady Bratslavsky, Joseph M Jacob, et al.. (2022). Association of RB1 mutational status with overall genomic landscape in neuroendocrine prostate cancer (NEPC).. Journal of Clinical Oncology. 40(16_suppl). 5063–5063. 3 indexed citations

Haley, Lisa, Vamsi Parimi, Liqun Jiang, et al.. (2021). Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens. Journal of Molecular Diagnostics. 23(10). 1343–1358. 19 indexed citations

Park, Youngran, Ryoichi Asaka, Wenjing Shen, et al.. (2021). A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. Laboratory Investigation. 101(11). 1505–1512. 17 indexed citations

Matoso, Andrés, Vamsi Parimi, & Jonathan I. Epstein. (2021). Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall. Human Pathology. 113. 1–8. 3 indexed citations

10.

Achy, Samar El, Vamsi Parimi, Eric D. Donnelly, et al.. (2020). Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy. American Journal of Clinical Oncology. 44(2). 58–67. 12 indexed citations

11.

Sonn, Kevin A., Abhishek Kannan, Chawon Yun, et al.. (2015). Effect of recombinant human bone morphogenetic protein‐2 on a novel lung cancer spine metastasis model in rodents. Journal of Orthopaedic Research®. 34(7). 1274–1281. 4 indexed citations

12.

Zhou, Zheng, Juehua Gao, Relja Popovic, et al.. (2015). Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation. Leukemia & lymphoma. 56(10). 2895–2901. 27 indexed citations

13.

Ceppi, Paolo, Andrea E. Murmann, Sonia Brockway, et al.. (2014). Death Induced by CD95 or CD95 Ligand Elimination. Cell Reports. 7(1). 208–222. 58 indexed citations

14.

Zhu, Bing, et al.. (2014). Diagnostic accuracy of frozen-section analysis of cancer-containing bladder transurethral resection specimens for the presence of muscularis propria invasion. Journal of Clinical Pathology. 67(7). 562–565. 3 indexed citations

15.

Hamdan, Randala, Danijela Đokić, Vamsi Parimi, et al.. (2014). Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells. Cell Cycle. 13(20). 3191–3201. 29 indexed citations

16.

Clark, Allan, Michael Safaee, Tae-Min Oh, et al.. (2014). Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells. Journal of Translational Medicine. 12(1). 345–345. 25 indexed citations

17.

Wong, Stuart J., Bruce H. Campbell, Becky Massey, et al.. (2013). A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncology. 49(9). 970–976. 30 indexed citations

18.

Kaklamani, Virginia, Kalliopi P. Siziopikou, Denise Scholtens, et al.. (2011). Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib. Breast Cancer Research and Treatment. 132(3). 833–842. 27 indexed citations

19.

Ahn, Richard W., Feng Chen, Haimei Chen, et al.. (2010). A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer. Clinical Cancer Research. 16(14). 3607–3617. 105 indexed citations

20.

Mavanur, Arun, Vamsi Parimi, Mark E. O’Malley, et al.. (2010). Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma. International Journal of Experimental Pathology. 91(4). 357–367. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact